SINOMED(SH:688108) Sou Hu Cai Jing·2025-08-17 16:50Trading Information Summary - On August 15, 2025, Sino Medical (688108) closed at 34.57 CNY, up 13.72%, with a turnover rate of 17.2% and a trading volume of 715,600 lots, amounting to a total transaction value of 2.331 billion CNY [1] - The net inflow of main funds was 98.2166 million CNY, accounting for 4.21% of the total transaction value, while retail investors had a net outflow of 1.05 billion CNY, representing 4.51% of the total transaction value [1][3] Company Announcement Summary - Sino Medical's stock experienced a cumulative price deviation of 200% over 30 consecutive trading days, indicating severe abnormal trading fluctuations [1][3] - The company announced several significant updates: on July 22, a new drug-eluting stent system received conditional approval from the FDA; on July 25, the company released its half-year performance forecast for 2025; and on August 7, a subsidiary's product received breakthrough medical device designation from the FDA [1] - The company emphasized that its daily operations are normal, and there have been no significant changes in market conditions or industry policies affecting the stock's abnormal fluctuations [1]